Blanchard Claire, Moreau François, Cariou Bertrand, Le May Cédric
IRS-UN, institut du thorax, unité Inserm UMR 1087/CNRS UMR 6291, 8, quai Moncousu, 44007 Nantes Cedex 1, France.
Med Sci (Paris). 2014 Oct;30(10):896-901. doi: 10.1051/medsci/20143010017. Epub 2014 Oct 14.
The small intestine plays a crucial role in dietary and biliary cholesterol absorption, as well as its lymphatic secretion as chylomicrons (lipoprotein exogenous way). Recently, a new metabolic pathway called TICE (trans-intestinal excretion of cholesterol) that plays a central role in cholesterol metabolism has emerged. TICE is an inducible way, complementary to the hepatobiliary pathway, allowing the elimination of the plasma cholesterol directly into the intestine lumen through the enterocytes. This pathway is poorly characterized but several molecular actors of TICE have been recently identified. Although it is a matter of debate, two independent studies suggest that TICE is involved in the anti-atherogenic reverse cholesterol transport pathway. Thus, TICE is an innovative drug target to reduce -cardiovascular diseases.
小肠在膳食和胆汁胆固醇吸收以及其作为乳糜微粒的淋巴分泌(脂蛋白外源性途径)中起着关键作用。最近,一种在胆固醇代谢中起核心作用的新代谢途径——经肠胆固醇排泄(TICE)出现了。TICE是一种诱导性途径,是肝胆途径的补充,可使血浆胆固醇通过肠上皮细胞直接排入肠腔。该途径的特征尚不明确,但最近已鉴定出TICE的几个分子作用因子。尽管存在争议,但两项独立研究表明,TICE参与了抗动脉粥样硬化的逆向胆固醇转运途径。因此,TICE是降低心血管疾病的一个创新药物靶点。